Why nordisk Is Trending Today?

Novo Nordisk, a leading pharmaceutical company, has appointed a new CEO who is already executing a focused strategy, notably with the acquisition of Akero Therapeutics. This acquisition, valued at up to $5.2 billion, is part of the new CEO's push to revive the company's growth. The news of this deal has significantly impacted the stock market, with Akero Therapeutics' shares trouncing the market on Thursday. Other companies in the sector, such as Viking Therapeutics, Genfit, and Sagimet, also saw their stocks jump in response to this development.